How to Choose a Stem Cell Hospital in China: A Patient's Due Diligence Guide

Why Due Diligence Is Essential

China's stem cell landscape spans the full spectrum from world-class academic research centers conducting rigorous NMPA-registered clinical trials to unregulated commercial clinics making unsubstantiated claims. The same country hosts both categories, and the marketing materials of disreputable providers often mimic the language of legitimate institutions.

This guide gives you a concrete, step-by-step framework to evaluate any stem cell provider in China before committing to treatment.

Step 1: Verify the Hospital Classification

China's hospital classification system uses a three-tier, three-grade structure. For stem cell therapy, you should only consider Class 3 Grade A (三级甲等) hospitals — the highest classification, covering fewer than 2,000 hospitals nationally. These institutions have:

• Full specialist departments including hematology, oncology, rheumatology, and neurology
• Institutional Review Boards (IRBs) capable of overseeing clinical research
• Accountability to the National Health Commission's inspection system

Verification: Search the hospital name on the NHC's official hospital query system (卫生健康委医院查询系统). The hospital's Grade 3A status should be listed.

Private clinics — regardless of how impressive their facilities appear — do not meet this standard for stem cell therapy. Some offer legitimate services, but the accountability and institutional oversight structure is fundamentally different.

Step 2: Find the Trial Registration Number

Every legitimate stem cell treatment in China for an unapproved indication must be conducted within a registered clinical trial. Ask the provider: "What is the CDE trial registration number for this treatment?"

Then verify it independently:

1. Go to chinadrugtrials.org.cn (CDE Clinical Trial Registry)
2. Enter the trial registration number or search by institution name and condition
3. Confirm: Is the trial currently recruiting? Does the patient profile match your condition? Is the institution listed?

You can also cross-reference with the WHO International Clinical Trials Registry Platform (ICTRP) at who.int/ictrp — Chinese trials registered in the CDE system are uploaded to the ICTRP database.

If the provider cannot give you a trial registration number, walk away.

Step 3: Ask About Cell Manufacturing

The quality of the stem cell product matters as much as the hospital administering it. Ask specifically:

• "Is the cell product manufactured in an NMPA-certified GMP facility?"
• "Can you provide the manufacturing facility's NMPA certification number?"
• "What are the release testing criteria for each cell batch (viability, sterility, identity, potency)?"
• "Is the cell product allogeneic (donor-derived) or autologous (from my own body)?"

Reputable centers will answer these questions specifically and in writing. Evasive answers or inability to provide GMP documentation is a significant red flag.

Step 4: Evaluate the Physician and Department

The physician leading your treatment should be a specialist in the disease area relevant to your condition — not a generalist or aesthetics practitioner. For autoimmune conditions, the treating physician should be a rheumatologist; for neurological conditions, a neurologist with specific cell therapy experience; for hematological conditions, a hematologist.

Request to review:

• The principal investigator's published research record (search PubMed for their name)
• The department's specific experience with your condition (number of patients treated, published outcomes)
• Whether the physician will personally consult with you before enrollment, or whether your case is handled by a commercial liaison with no medical training

Step 5: Understand the Cost Structure

As emphasized throughout our content: legitimate clinical trials do not charge patients for the investigational cell therapy itself. The NMPA and NHC regulations explicitly prohibit charging for investigational treatments.

What you may legitimately be charged for:

• Medical consultations and specialist assessments
• Diagnostic testing (imaging, labs) performed before or during treatment
• Standard-of-care medications used alongside investigational therapy
• Hospital accommodation if inpatient stay is required
• International coordination and interpretation services (legitimate service fees)

What you should not be charged for:

• The stem cell product itself (in a legitimate clinical trial)
• "Application fees" or "trial enrollment fees"
• Any service framed as "paying to access the trial"

Step 6: Request the Informed Consent Documentation

Before enrolling in any clinical trial, you have the right to receive a complete informed consent document that includes:

• The nature of the investigational treatment
• Known risks and potential benefits
• Alternative treatment options
• Your right to withdraw without penalty
• Contact details for the ethics committee

Request this document in advance (not just upon arrival at the hospital). Ask for a version in your language. If the provider is unwilling to provide this in advance, treat it as a serious red flag.

How Panda Touring Care Applies This Framework

We apply all six steps above before working with any clinical partner. Our hospital network is limited to Class 3A institutions with active CDE-registered trials and published research records in their respective disease areas. We can share trial registration numbers and principal investigator publication records for any program we recommend before you make any commitment.

Sources: NHC Hospital Management Regulations; NMPA Clinical Trial Quality Management Regulations 2020; WHO ICTRP registry standards; China Drug Trials official guidance documentation.